Hearing on “Examining How Covered Entities Utilize the 340B Drug Pricing Program,” Subcommittee on Oversight and Investigations (October 11, 2017)
The Subcommittee on Oversight and Investigations held a hearing on Wednesday, October 11, 2017, at 10:00 a.m. in 2123 Rayburn House Office Building. The hearing is entitled “Examining How Covered Entities Utilize the 340B Drug Pricing Program.”
Livestream
Key Documents
Memorandum from Ranking Member Pallone to the Subcommittee on Oversight and Investigations
Opening Statement of Ranking Member Pallone as prepared for delivery
Witnesses
Michael Gifford
President and Chief Executive Officer
AIDS Resource Center of Wisconsin
Sue Veer, MBA, CMPE
President and Chief Executive Officer
Carolina Health Centers
Charles Reuland, MHS, Sc.D
Executive Vice President and Chief Operating Officer
Johns Hopkins Hospital
Ronald Paulus, MD
President and Chief Executive Officer
Mission Health
Shannon Banna
Director of Finance and System Controller
Northside Hospital